- (PLX AI) - Fresenius Medical faces a tough third-quarter earnings report, with consensus that may be too high, analysts at Bank of America said.
- • Fresenius Medical is scheduled to report on Nov. 2
- • The company may be tracking toward the bottom end of its guidance range as excess mortality is still running at elevated levels, BofA said
- • BofA rates Fresenius Medical neutral, with price target EUR 69
BANK OF AMERICA-Aktie komplett kostenlos handeln - auf Smartbroker.de